Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SNS-023 sensitizes hepatocellular carcinoma to sorafenib by inducing degradation of cancer drivers SIX1 and RPS16
Yuan Liu, Weiyao Kong, Cuifu Yu, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 4, pp. 853-864
Closed Access | Times Cited: 19

Showing 19 citing articles:

SERPINE2 promotes liver cancer metastasis by inhibiting c‐Cbl‐mediated EGFR ubiquitination and degradation
Shiyu Zhang, Xing Jia, Haojiang Dai, et al.
Cancer Communications (2024) Vol. 44, Iss. 3, pp. 384-407
Open Access | Times Cited: 14
Biological impact and therapeutic implication of tumor-associated macrophages in hepatocellular carcinoma
Deming Li, Ting Zhang, Ye Guo, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 10
Ubiquitin-specific peptidase 1: assessing its role in cancer therapy
Peng Huang, Yuhan Wang, Pengfei Zhang, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 2953-2966
Closed Access | Times Cited: 15
HSP90β Impedes STUB1‐Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma
Yuning Liao, Yuan Liu, Cuifu Yu, et al.
Advanced Science (2023) Vol. 10, Iss. 27
Open Access | Times Cited: 15
The other side of the coin: protein deubiquitination by Ubiquitin-Specific Protease 1 in cancer progression and therapy
Xinlan Hu, Yan Wu, Mengmeng Yao, et al.
Future Medicinal Chemistry (2025) Vol. 17, Iss. 3, pp. 329-345
Closed Access
Potentiation of Sorafenib’s Action by Berberine via Suppression of the mTOR Signaling Pathway in Human Hepatoma Cells
Rongrong Zhang, Na Wang, Bo Fan, et al.
Nutrition and Cancer (2025), pp. 1-13
Closed Access
The role of homeobox gene Six1 in cancer progression and its potential as a therapeutic target: A review
Yong Jin, Xinran Xie, Hongbin Li, et al.
International Journal of Biological Macromolecules (2025), pp. 142666-142666
Closed Access
Tumor-suppressive activities for pogo transposable element derived with KRAB domain via ribosome biogenesis restriction
Zhenbo Tu, Mahmoud A. Bassal, George W. Bell, et al.
Molecular Cell (2024) Vol. 84, Iss. 21, pp. 4209-4223.e6
Closed Access | Times Cited: 3
A prognostic and immune related risk model based on zinc homeostasis in hepatocellular carcinoma
Yifei Shi, Runxin Ye, Yuan Gao, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109389-109389
Open Access | Times Cited: 2
Retinal determination gene networks: from biological functions to therapeutic strategies
Shuangli Zhu, Wanling Li, Hao Zhang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 5
Decoding the Role of O-GlcNAcylation in Hepatocellular Carcinoma
Xinyu Zhou, Sirui Hang, Qingqing Wang, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 908-908
Open Access | Times Cited: 1
Implications of ITCH-mediated ubiquitination of SIX1 on CDC27-cyclinB1 signaling in nasopharyngeal carcinoma
Zehua Lin, Weisong Cai, Ying Sun, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
The Ku70-SIX1-GPT2 axis regulates alpha-ketoglutarate metabolism to drive progression of prostate cancer
Hongbiao Huang, Xuefen Zhuang, Shusha Yin, et al.
Oncogene (2024)
Closed Access | Times Cited: 1
METTL14-mediated m6A modification enhances USP22-ERα axis to drive breast cancer malignancy
Xuefen Zhuang, Shusha Yin, Cheng Ji, et al.
Pharmacological Research (2024) Vol. 210, pp. 107509-107509
Open Access | Times Cited: 1
SENP3 mediates deSUMOylation of SIX1 to promote prostate cancer proliferation and migration
Zhenlong Shao, Shutong Liu, Wenshuang Sun, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Discovery of novel, orally bioavailable phenylacetamide derivatives as multikinase inhibitors and in vivo efficacy study in hepatocellular carcinoma animal models
Debasis Das, Lingzhi Xie, Dandan Qiao, et al.
Bioorganic & Medicinal Chemistry Letters (2024), pp. 129971-129971
Closed Access
Overexpression pattern, function, and clinical value of proteasome 26S subunit non-ATPase 6 in hepatocellular carcinoma
Shengsheng Zhou, Yuping Ye, Yi Chen, et al.
World Journal of Clinical Oncology (2024) Vol. 16, Iss. 2
Closed Access
Ku70 Targets BRD3-MYC/Cyclin D1 Axis to Drive Hepatocellular Carcinoma Progression
Wenshuang Sun, Ji Cheng, Ruijun Zhao, et al.
Experimental Cell Research (2024) Vol. 444, Iss. 2, pp. 114404-114404
Closed Access
Sine oculis homeobox homolog family function in gastrointestinal cancer: Progression and comprehensive analysis
Yang-Zheng Lan, Zheng Wu, Wen-Jia Chen, et al.
World Journal of Clinical Oncology (2024) Vol. 16, Iss. 1
Closed Access
Page 1

Scroll to top